A highly stable, anti-crystallization sodium dichlorophenate microcapsule suspension and its continuous flow preparation process in a microreactor
By employing microencapsulated sustained-release technology and microchannel continuous flow process, the problems of easy crystallization and hydrolysis of bispyribac sodium salt have been solved, enabling its widespread application in paddy fields in both northern and southern China. This has improved the stability and production efficiency of the formulation, reduced the risk of phytotoxicity, and made it suitable for the industrial production of highly stable pesticide formulations.
Patent Information
- Application Number
- CN202611380111.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-07
- Publication Date
- 2026-11-17
AI Technical Summary
Sodium bispyribac-sodium has high water solubility at room temperature and is easily affected by temperature and pH fluctuations, leading to crystallization and hydrolysis. Conventional suspensions are prone to stratification and sedimentation at low temperatures, and can easily cause phytotoxicity when used in cold northern regions. Traditional preparation processes have problems such as uneven particle size, low encapsulation rate, and large temperature fluctuations, making it difficult to achieve widespread application in rice fields in both the north and south.
By employing microencapsulation sustained-release technology and microchannel continuous flow process, and optimizing the salt-tolerant buffer compound formulation, dense polyurea microcapsules were prepared using isophorone diisocyanate and hexamethylene diisocyanate compound as capsule wall monomers, combined with N-methylpyrrolidone and propylene carbonate compound solvents, anionic and nonionic surfactant compound emulsifying and dispersing agents, triethanolamine and sodium dihydrogen phosphate buffer salt stabilizer, xanthan gum thickening and stabilizing agent, and ethylene glycol antifreeze agent. Continuous emulsification and polymerization were carried out using a microreactor to achieve high stability and uniform particle size.
It achieves high stability of bispyribac sodium salt microcapsule suspension, avoids low-temperature crystallization and hydrolysis, reduces the risk of phytotoxicity, is suitable for paddy fields in both the north and south, extends the effective period to 36-46 days, improves production efficiency and batch consistency, reduces energy consumption and waste emissions, and is suitable for large-scale industrial application.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] This invention belongs to the field of pesticide formulation processing technology, specifically relating to a highly stable anti-crystallization sodium dichlorophenate microcapsule suspension and its continuous flow preparation process using a microreactor. Background Technology
[0002] Bismuth subsalicylate sodium salt is a highly active systemic herbicide specifically for rice paddies. It effectively controls annual broadleaf weeds and sedges such as barnyard grass, duckweed, sedge, and pondweed. It has a low dosage and a broad spectrum of herbicidal activity, making it widely used in rice-growing areas of southern China. However, bismuth subsalicylate sodium salt has a high water solubility of 73.3 g / L at room temperature, far exceeding that of bismuth subsalicylate potassium salt. This high water solubility leads to several drawbacks: First, the high degree of sodium ionization makes it highly susceptible to temperature and pH fluctuations in aqueous solutions, easily precipitating needle-like crystals at low temperatures, causing nozzle clogging. Second, it is highly prone to hydrolysis in acidic environments; conventional suspension concentrates can experience over 5% hydrolysis of the active ingredient after 30 days of storage. Third, the high surface activity of sodium salt makes it difficult to stabilize in conventional emulsion systems, leading to stratification, sedimentation, and oil floating phenomena during long-term storage.
[0003] Meanwhile, conventional formulations of bispyribac sodium (suspension, wettable powder, and water-dispersible granules) have serious regional limitations: it is safe to use in southern rice-growing areas, but in northern cold-climate japonica rice-growing areas, due to low water temperature, slow rice metabolism, and rapid pesticide absorption, the rapid release can easily lead to excessively high local concentrations, causing phytotoxicity such as stunted seedlings, yellowing, dwarfing, and tiller inhibition, making it difficult to apply bispyribac sodium on a large scale in northern cold-climate rice-growing areas.
[0004] Currently, all commercially available sodium bispyribac-sodium formulations are either ordinary suspensions or wettable powders, with no microencapsulated formulations available. Traditional preparation processes using batch stirred reactors have significant drawbacks for high-salt sodium systems: 1. Uneven shear mixing, resulting in severe sodium particle agglomeration, wide particle size distribution, and PDI generally greater than 0.32; 2. Poor interfacial film stability, making it impossible to achieve efficient encapsulation of high-salt systems, with conventional encapsulation rates only reaching 77%~84%; 3. Large temperature fluctuations in batch processes, with low-temperature preparation easily inducing sodium crystallization, leading to high product scrap rates; 4. Significant differences in physicochemical properties between batches, with obvious fluctuations in hydrolysis rates, making industrial-scale quality control difficult.
[0005] Therefore, developing a formulation and its continuous preparation process that can solve the problems of low-temperature crystallization, easy hydrolysis, poor storage stability, low adaptability to intermittent processes, and susceptibility to herbicide damage in cold-weather rice in northern regions, has significant market value and practical significance. Summary of the Invention
[0006] In view of this, the technical problem to be solved by the present invention is to provide a highly stable sodium dihydrochloride microcapsule suspension with anti-crystallization properties and its microreactor continuous flow preparation process. The present invention optimizes the salt-tolerant buffer compound formulation, combines microcapsule sustained-release and controlled-release technology with microchannel continuous flow process, inhibits sodium salt crystallization and hydrolysis, improves the storage stability of the formulation, reduces the risk of low-temperature phytotoxicity, and enables it to be used in rice fields in both the north and south.
[0007] This invention provides a highly stable, anti-crystallization sodium dihydrochloride microcapsule suspension, made from the following raw materials in the indicated mass percentages:
[0008] Bismuth subsalicylate sodium salt 5.0%~50.0%, capsule wall monomer 2.2%~8.5%, complex organic solvent 3.2%~14%, salt-resistant emulsifying dispersant 1.8%~5.2%, buffer salt stabilizer 0.25%~1.2%, thickener stabilizer 0.12%~0.55%, antifreeze 2.2%~5.5%, deionized water to 100%;
[0009] The capsule wall monomer is selected from a mixture of isophorone diisocyanate and hexamethylene diisocyanate;
[0010] The composite organic solvent is a mixture of N-methylpyrrolidone and propylene carbonate.
[0011] The salt-resistant emulsifying dispersant is a compound system of anionic and nonionic surfactants.
[0012] Preferably, the mass ratio of isophorone diisocyanate to hexamethylene diisocyanate is 2.2:1 to 4.2:1.
[0013] Preferably, the mass ratio of N-methylpyrrolidone to propylene carbonate is 1:4 to 4:1; more preferably, it is 1:1 to 3:1.
[0014] Preferably, the anionic surfactant is selected from sodium alkylnaphthalene sulfonate;
[0015] The nonionic surfactant is selected from polyoxyethylene castor oil ether;
[0016] The mass ratio of the anionic surfactant to the nonionic surfactant is 1:1.2 to 1:4.2.
[0017] Preferably, the buffer salt stabilizer is a mixture of triethanolamine and sodium dihydrogen phosphate, wherein the mass ratio of triethanolamine to sodium dihydrogen phosphate is 1:1.8 to 1:2.4.
[0018] Preferably, the thickening stabilizer is xanthan gum; and the antifreeze agent is ethylene glycol.
[0019] Preferably, the microcapsule suspension has a median particle size D50 of 1.0~2.8 μm, a particle size distribution index (PDI) ≤0.17, a microcapsule encapsulation efficiency ≥95.2%, and a suspension efficiency ≥98.2%.
[0020] The thermal storage stability conditions of the microcapsule suspension are: 54±2℃ sealed storage for 14 days, with a decomposition rate of ≤5%; and the cold storage stability conditions are: 0±2℃ storage for 14 days, with no stratification, no precipitation, and no sodium salt crystallization.
[0021] The present invention also provides a method for preparing the above-mentioned microcapsule suspension, comprising the following steps:
[0022] A) Prepare oil-phase liquid and aqueous-phase liquid separately;
[0023] The oil phase liquid comprises sodium bispyribac-sodium salt, capsule wall monomers, and a complex organic solvent;
[0024] The aqueous phase liquid comprises a salt-resistant emulsifying dispersant, a buffer salt stabilizer, an antifreeze agent, and water;
[0025] B) The oil phase liquid and the aqueous phase liquid are continuously emulsified through a microreactor to obtain an emulsion;
[0026] C) The emulsion is polymerized and solidified to obtain polyurea-coated bis(propargyl) sodium salt microcapsules;
[0027] D) The polyurea-coated sodium bispyribac-sodium salt microcapsules are post-processed and formulated to obtain the finished sodium bispyribac-sodium salt microcapsule suspension.
[0028] Preferably, in step B), the microreactor is a cross-shaped microchannel reactor with an inner diameter of 550~950μm and an internal multi-layer shear diversion structure.
[0029] The volume ratio of oil phase liquid to aqueous phase liquid feed is 1:1.5 to 1:4.5, and the feed accuracy of oil phase liquid and aqueous phase liquid is controlled at ±0.8%.
[0030] The internal temperature of the microreactor is controlled at 43~63℃, the internal working pressure is 0.18~0.38MPa, the shear flow rate is 145~310mL / min, and the residence time is 18~48s.
[0031] Preferably, in step C), the polymerization and curing are carried out under constant temperature conditions of 52~68℃ with continuous stirring for 2.2~4.2h;
[0032] The polymerization and solidification are carried out in a tubular reactor, which is equipped with a jacketed constant temperature control system and a stirring speed of 85~145 r / min, and the reaction is carried out in a closed and continuous manner.
[0033] Compared with the prior art, the present invention provides a highly stable, anti-crystallization sodium bispyrazine microcapsule suspension, which is made from the following raw materials in the indicated mass percentages: sodium bispyrazine 5.0%~50.0%, capsule wall monomer 2.2%~8.5%, composite organic solvent 3.2%~14%, salt-resistant emulsifying dispersant 1.8%~5.2%, buffer salt stabilizer 0.25%~1.2%, thickening stabilizer 0.12%~0.55%, antifreeze 2.2%~5.5%, and deionized water to 100%; the capsule wall monomer is selected from a mixture of isophorone diisocyanate and hexamethylene diisocyanate; the composite organic solvent is a mixture of N-methylpyrrolidone and propylene carbonate; and the salt-resistant emulsifying dispersant is a mixture of anionic and nonionic surfactants. The anti-crystallization, highly stable sodium bispyribac-sodium salt microcapsule suspension provided by this invention achieves controlled sustained release through the polyurea capsule wall, avoiding phytotoxicity caused by the sudden release of active ingredients under low-temperature conditions. It can be safely applied to cold-region japonica rice fields in northern China, solving the problem that traditional formulations are only suitable for southern rice and prone to phytotoxicity in northern cold-region rice. This invention achieves universal applicability in rice fields in both the north and south. This invention effectively solves the problems of easy hydrolysis, low-temperature crystallization, and storage stratification of sodium bispyribac-sodium salt. The formulation has excellent sustained-release properties, with a weed control effect in rice fields lasting 36-46 days. It has high safety for rice seedlings, strong controllability for continuous production, and is suitable for large-scale industrial application. Detailed Implementation
[0034] This invention provides a highly stable, anti-crystallization sodium dihydrochloride microcapsule suspension, made from the following raw materials in the indicated mass percentages:
[0035] Bismuth subsalicylate sodium salt 5.0%~50.0%, capsule wall monomer 2.2%~8.5%, complex organic solvent 3.2%~14%, salt-resistant emulsifying dispersant 1.8%~5.2%, buffer salt stabilizer 0.25%~1.2%, thickener stabilizer 0.12%~0.55%, antifreeze 2.2%~5.5%, deionized water to 100%;
[0036] The capsule wall monomer is selected from a mixture of isophorone diisocyanate and hexamethylene diisocyanate;
[0037] The composite organic solvent is a mixture of N-methylpyrrolidone and propylene carbonate.
[0038] The salt-resistant emulsifying dispersant is a compound system of anionic and nonionic surfactants.
[0039] The raw material of the bispyribac sodium salt microcapsule suspension provided by the present invention includes 5.0% to 50.0% bispyribac sodium salt, which can be any value between 5.0%, 10.0%, 15.0%, 20.0%, 25.0%, 30.0%, 35.0%, 40.0%, 45.0%, 50.0%, or 5.0% to 50.0%.
[0040] The raw materials for the sodium bispyribac-sodium microcapsule suspension provided by this invention further include 2.2% to 8.5% of the capsule wall monomer, which can be any value between 2.2%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, or 2.2% to 8.5%. The capsule wall monomer is selected from a mixture of isophorone diisocyanate and hexamethylene diisocyanate; the mass ratio of isophorone diisocyanate to hexamethylene diisocyanate is 2.2:1 to 4.2:1, which can be 2.2:1, 2.5:1, 3.0:1, 3.2:1, 3.6:1, 4.0:1, 4.2:1, or any ratio between 2.2:1 and 4.2:1, preferably 3.2:1. This invention uses a mixture of isophorone diisocyanate and hexamethylene diisocyanate as the capsule wall monomer to form a dense and tough polyurea capsule wall, which blocks water molecule penetration and reduces the hydrolysis rate of sodium salt.
[0041] The raw materials for the sodium bispyrazine salt microcapsule suspension provided by this invention further include a composite organic solvent of 3.2% to 14%, which can be any value between 3.2%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, 9.5%, 10.0%, 10.5%, 11%, 12%, 13%, 14%, or 3.2% to 14%. The composite organic solvent is a compound solvent of N-methylpyrrolidone and propylene carbonate, and the mass ratio of N-methylpyrrolidone to propylene carbonate is 1:4 to 4:1, which can be 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1, or any ratio between 1:4 and 4:1, preferably any ratio between 1:1 and 3:1. In this invention, the composite organic solvent is a combination of N-methylpyrrolidone and propylene carbonate, which has excellent solubility for sodium salts and inhibits solute precipitation at low temperatures.
[0042] The raw materials for the sodium bispyribac-sodium salt microcapsule suspension provided by this invention further include 1.8% to 5.2% of a salt-tolerant emulsifying dispersant, which can be any value between 1.8%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.2%, or 1.8% to 5.2%. The salt-tolerant emulsifying dispersant is a compound system of anionic and nonionic surfactants. The anionic surfactant is selected from sodium alkylnaphthalene sulfonate; the nonionic surfactant is selected from polyoxyethylene castor oil ether; the mass ratio of the anionic surfactant to the nonionic surfactant is 1:1.2 to 1:4.2, which can be any ratio between 1:1.2, 1:1.5, 1:1.7, 1:2.0, 1:2.2, 1:2.5, 1:2.7, 1:3.0, 1:3.2, 1:3.5, 1:3.7, 1:4.0, 1:4.2, or 1:1.2 to 1:4.2. The emulsifying dispersant is a compound of salt-resistant alkylnaphthalene sulfonate sodium and polyoxyethylene castor oil ether, which can reduce the oil-water interfacial tension in high-salt systems and prevent microcapsule aggregation and adhesion. The emulsifying dispersant is suitable for high-salt sodium salt systems, inhibiting sodium salt aggregation and precipitation.
[0043] The raw materials for the sodium bismuth subsalicylate microcapsule suspension provided by this invention further include a buffer salt stabilizer of 0.25% to 1.2%, which can be any value between 0.25%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0%, 1.1%, 1.2%, or 0.25% to 1.2%. The buffer salt stabilizer is a compound of triethanolamine and sodium dihydrogen phosphate, with a compound mass ratio of triethanolamine to sodium dihydrogen phosphate of 1:1.8 to 1:2.4, which can be any ratio between 1:1.8, 1:1.9, 1:2.0, 1:2.1, 1:2.2, 1:2.3, 1:2.4, or 1:1.8 to 1:2.4. The buffer salt stabilizer uses triethanolamine combined with sodium dihydrogen phosphate to regulate the pH of the system to 7.2~8.8, constructing a wide-range buffer system that can stabilize the system pH, resist external acid and alkali fluctuations, and further inhibit sodium salt dissociation and hydrolysis.
[0044] The raw materials for the sodium bispyrazine microcapsule suspension provided by this invention further include a thickening and stabilizing agent of 0.12% to 0.55%, which can be any value between 0.12%, 0.15%, 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 0.55%, or 0.12% to 0.55%. In this invention, the thickening and stabilizing agent is xanthan gum.
[0045] The raw materials for the sodium bispyribac-sodium microcapsule suspension provided by this invention further include 2.2% to 5.5% antifreeze, which can be any value between 2.2%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, or 2.2% to 5.5%. In this invention, the antifreeze is ethylene glycol.
[0046] In this invention, the median particle size D50 of the microcapsule suspension is 1.0~2.8 μm, the particle size is uniform, the particle size distribution coefficient PDI is ≤0.17, there are no large sodium salt agglomerates, the microcapsule encapsulation efficiency is ≥95.2%, and the suspension efficiency is ≥98.2%.
[0047] The microcapsule suspension exhibits the following thermal stability conditions: after 14 days of sealed storage at 54±2℃, the decomposition rate is ≤5%; under cold storage conditions: after 14 days of storage at 0±2℃, there is no stratification, precipitation, or sodium salt crystallization. The shelf life at room temperature can reach 24 months, demonstrating a significant improvement in storage stability.
[0048] This invention achieves uniform and sustained release of bispyribac-sodium salt through the polyurea capsule wall, avoiding phytotoxicity caused by sudden release of active ingredients under low temperature conditions. It is highly safe for japonica rice in cold northern regions and breaks through the limitation of traditional formulations that are only applicable to southern rice, making it suitable for both northern and southern rice fields.
[0049] The microcapsule suspension provided by this invention reduces the risk of low-temperature phytotoxicity through slow-release and controlled-release. It can be safely used for the control of broadleaf weeds and sedges in direct-seeded rice fields and transplanted rice fields in the south, as well as in cold-region japonica rice areas in the north. The effective period after application is 36-46 days, and there is no phytotoxicity to rice seedlings or tillering stages.
[0050] The present invention also provides a method for preparing the above-mentioned microcapsule suspension, comprising the following steps:
[0051] A) Prepare oil-phase liquid and aqueous-phase liquid separately;
[0052] The oil phase liquid comprises sodium bispyribac-sodium salt, capsule wall monomers, and a complex organic solvent;
[0053] The aqueous phase liquid comprises a salt-resistant emulsifying dispersant, a buffer salt stabilizer, an antifreeze agent, and water;
[0054] B) The oil phase liquid and the aqueous phase liquid are continuously emulsified through a microreactor to obtain an emulsion;
[0055] C) The emulsion is polymerized and solidified to obtain polyurea-coated bis(propargyl) sodium salt microcapsules;
[0056] D) The polyurea-coated sodium bispyribac-sodium salt microcapsules are post-processed and formulated to obtain the finished sodium bispyribac-sodium salt microcapsule suspension.
[0057] Specifically, at room temperature, the technical grade of bispyribac-sodium salt is dissolved in a composite organic solvent, and the capsule wall monomer is added. The mixture is stirred at a constant speed for 18-28 minutes to prepare a uniform and transparent oil phase liquid.
[0058] Salt-resistant emulsifying dispersant, buffer salt stabilizer, and antifreeze were added sequentially to deionized water, stirred to dissolve, and the buffer threshold of the system was adjusted to prepare a homogeneous and stable aqueous phase liquid.
[0059] The oil phase liquid and the aqueous phase liquid are quantitatively delivered to the microreactor by constant flow pumps. The volume ratio of the oil phase liquid to the aqueous phase liquid feed is 1:1.5 to 1:4.5, which can be any ratio between 1:1.5, 1:2.5, 1:3.5, 1:4.5, or 1:1.5 to 1:4.5.
[0060] The feed accuracy of the oil phase liquid and the aqueous phase liquid is controlled at ±0.8%. The internal working pressure of the microreactor is 0.18~0.38MPa, which can be any value between 0.18, 0.2, 0.25, 0.3, 0.35, 0.38, or 0.18~0.38MPa, which can achieve precise control of emulsification dispersion and reduce the probability of sodium salt crystallization.
[0061] The internal temperature of the microreactor is controlled at 43~63℃, which can be any value between 43, 45, 50, 55, 60, 63, or 43~63℃; the shear flow rate is 145~310mL / min, which can be any value between 145, 150, 175, 200, 225, 250, 275, 300, 310, or 145~310mL / min; and the residence time is 18~48s, which can be any value between 18, 20, 25, 30, 35, 40, 45, 48, or 18~48s.
[0062] The microreactor is a cross-shaped microchannel reactor with an inner diameter of 550~950μm, which can be any value between 550, 600, 650, 700, 750, 800, 850, 900, 950, or 550~950μm. The cross-shaped microchannel reactor has a multi-layer shear diversion structure inside, which is suitable for high-salt oil-water systems and prevents sodium salt agglomeration and adhesion.
[0063] Microreactor continuous flow technology, with its advantages of strong shearing in microchannels, millisecond-level rapid mixing, and precise isostatic control, can achieve rapid oil-water dispersion in high-salt systems and suppress ion aggregation and crystallization. Through the above steps, continuous and rapid emulsification is completed, resulting in a stable emulsion with uniform particle size.
[0064] The emulsion is polymerized and solidified to obtain polyurea-coated bis(oxalam) sodium salt microcapsules. The polymerization and solidification are carried out under constant temperature (52-68°C) with continuous stirring for 2.2-4.2 hours. The polymerization and solidification temperature is 52-68°C, which can be any value between 52, 55, 60, 65, and 68°C, or 2.2-4.2 hours.
[0065] The polymerization and solidification are carried out in a tubular reactor, which is equipped with a jacketed constant temperature control system and a stirring speed of 85~145 r / min, which can be any value between 85, 90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140, 145, or 85~145 r / min. The polymerization and solidification is a fully closed and continuous reaction with no intermediate material transfer, which reduces the hydrolysis and deterioration of sodium salt upon contact with air.
[0066] The polyurea-coated sodium bispyribac-sodium salt microcapsules were post-processed and formulated to obtain the finished sodium bispyribac-sodium salt microcapsule suspension.
[0067] Specifically, the process includes the following steps: after the polymerization and curing reaction is completed, the system is cooled to room temperature, a thickening and stabilizing agent is added, the mixture is stirred at low speed until homogeneous, and after filtration to remove impurities, the product is continuously discharged to obtain the finished product of sodium bispyribac-sodium microcapsule suspension.
[0068] This invention provides a microreactor continuous flow preparation process for the above-mentioned formulations. It optimizes continuous flow parameters for high-sodium salt systems, replacing traditional batch production with a closed, continuous process. This allows for precise control of emulsification shear strength, polymerization temperature, and residence time, completely solving the problems of sodium salt crystallization and agglomeration. The core of the process involves independent preparation of the oil and aqueous phases, pre-stabilization treatment of the buffer system, rapid emulsification under strong shear within microchannels, low-temperature and gentle polymerization in a tubular reactor, and fully closed, automated production with no interrupted material transfer, preventing sodium salt from deteriorating upon contact with air.
[0069] This invention applies a continuous flow process using a microreactor to prepare sodium bis(oxalyl) salt microcapsules. By utilizing the strong shear and rapid mixing characteristics of microchannels, it solves the problems of difficult emulsification and easy stratification in high-salt oil-water systems. The reaction parameters are precisely controllable, with batch-to-batch particle size deviation ≤1.8%, and excellent batch consistency.
[0070] Compared to traditional intermittent processes, the preparation process provided by this invention does not require batch start-up and shutdown, increasing production efficiency by approximately 1.6 times; reducing energy consumption by 26% to 36%; eliminating open volatilization of organic solvents; resulting in low emissions of waste; and preventing sodium salts from absorbing moisture and deteriorating during closed production, thus meeting the requirements for green and low-carbon industrial production of pesticides.
[0071] The microcapsule suspension provided by this invention has a dense polyurea capsule wall that enables uniform and slow release, avoiding the loss of sodium salts, extending the effective period in paddy fields to 36-46 days, and reducing the frequency of application. The formulation is safe for direct-seeded and transplanted rice throughout its entire growth period in southern China. At the same time, the slow and controlled release effectively reduces the risk of low-temperature phytotoxicity. It does not cause phytotoxicity to cold-region japonica rice during the seedling and tillering stages in northern China, making it suitable for use in paddy fields in both the north and south. The comprehensive weed control rate is ≥96.5% 15 days after application.
[0072] This invention uses sodium bispyribac-sodium as the herbicidal active ingredient, and prepares a dense polyurea capsule wall by compounding isocyanate. It is combined with a salt-resistant compound emulsification and dispersion system and a buffer salt stabilization system to inhibit the ionization and precipitation of sodium salt. At the same time, a microreactor continuous flow process is used to replace the traditional batch reactor. Taking advantage of the strong shear, millisecond-level rapid mixing, precise temperature control and narrow residence time distribution of the microreactor, continuous feeding of oil and water two phases, continuous emulsification and continuous interfacial polymerization and solidification are achieved.
[0073] To further understand the present invention, the following description, in conjunction with embodiments, illustrates the anti-crystallization highly stable sodium dihydrochloride microcapsule suspension and its continuous flow preparation process in a microreactor provided by the present invention. The scope of protection of the present invention is not limited by the following embodiments.
[0074] Example 1: 15% Sodium Bismuth Substrate Microcapsule Suspension
[0075] 1. Formula composition (percentage by mass)
[0076] 15.0% sodium bis(propargyl) ether, 4.8% isophorone diisocyanate, 1.5% hexamethylene diisocyanate, 5.2% N-methylpyrrolidone, 2.1% propylene carbonate, 1.1% sodium alkylnaphthalene sulfonate, 2.6% polyoxyethylene castor oil ether, 0.18% triethanolamine, 0.35% sodium dihydrogen phosphate, 0.22% xanthan gum, 3.2% ethylene glycol, and deionized water to bring the total to 100%.
[0077] 2. Preparation process
[0078] (1) Preparation of oil phase: At room temperature, 150g of bispyribac sodium salt technical material was added to 52g of N-methylpyrrolidone and 21g of propylene carbonate composite solvent. After stirring and dissolving, 48g of isophorone diisocyanate and 15g of hexamethylene diisocyanate were added. The mixture was stirred at a constant speed for 22min to obtain a clear and homogeneous oil phase.
[0079] (2) Preparation of aqueous phase: Add 11g sodium alkyl naphthalene sulfonate, 26g polyoxyethylene castor oil ether, 1.8g triethanolamine, 3.5g sodium dihydrogen phosphate and 32g ethylene glycol to 637.5g deionized water, stir until completely dissolved, adjust the pH value to 8.0, construct a buffer salt-stabilizing system, and obtain a stable aqueous phase;
[0080] (3) Continuous emulsification: A cross-shaped microchannel reactor with an inner diameter of 800 μm was used. Multiple parallel microchannels were used, and the total liquid holding volume was about 115 mL. The oil phase and water phase were fed by constant flow pumps with a feed volume ratio of 1:2.5, a feed flow rate of 215 mL / min, a reaction temperature of 53℃, an internal pressure of 0.26 MPa, and a material residence time of 32 s to complete the continuous emulsification of the high-salt system.
[0081] (4) Polymerization and curing: The emulsion is continuously fed into the jacketed reactor, kept at a constant temperature of 58°C, and stirred at a speed of 115 r / min for 3.2 h to form dense polyurea microcapsules.
[0082] (5) Post-processing: Cool down to 25°C, add 2.2g xanthan gum, stir at low speed for 45min, filter with a 100-mesh filter, and continuously discharge to obtain the finished product.
[0083] 3. Product testing indicators
[0084] The median particle size D50 is 1.75 μm, PDI is 0.11, encapsulation efficiency is 97.8%, and suspension efficiency is 99.3%. The decomposition rate is 1.12% after 14 days of heat storage at 54℃. No crystallization or stratification is observed after 14 days of cold storage at 0℃. No significant deterioration is observed after 24 months of storage at room temperature.
[0085] Example 2: 8% Sodium Bismuth Substrate Microcapsule Suspension
[0086] Formula: 8.0% sodium bispyrazine, 3.2% capsule wall monomer (isophorone diisocyanate: hexamethylene diisocyanate = 3.0:1), 5.3% complex organic solvent (N-methylpyrrolidone: propylene carbonate = 1:1), 2.1% salt-resistant emulsifying dispersant (anionic surfactant: nonionic surfactant = 1:1.2), 0.32% buffer salt stabilizer (triethanolamine: sodium dihydrogen phosphate = 1:2.2), 0.3% xanthan gum, 2.6% ethylene glycol, balance deionized water.
[0087] The preparation process is the same as in Example 1.
[0088] Test parameters: D50=1.41μm, PDI=0.14, encapsulation efficiency 96.8%, no crystallization at low temperature.
[0089] Example 3: 40% Sodium Bismuth Substrate Microcapsule Suspension
[0090] Formula: 40.0% sodium bispyrazine, 7.8% capsule wall monomer (isophorone diisocyanate: hexamethylene diisocyanate = 3.6:1), 12% compound organic solvent (N-methylpyrrolidone: propylene carbonate = 1.5:1), 4.8% salt-resistant emulsifying dispersant (anionic surfactant: nonionic surfactant = 1:1.2), 1.1% buffer salt stabilizer (triethanolamine: sodium dihydrogen phosphate = 1:2.2), 0.16% xanthan gum, 4.2% ethylene glycol, balance deionized water.
[0091] The preparation process is the same as in Example 1.
[0092] Test parameters: D50=2.68μm, PDI=0.16, encapsulation efficiency 95.5%, thermal decomposition rate 1.71%.
[0093] Comparative Example 1
[0094] The formula is the same as in Example 1, but the preparation process is changed: a 500L batch reactor is used, the stirring speed is 600r / min, the emulsification time is 1.8h, the polymerization reaction is 6.5h, and the proportions of other raw materials are the same.
[0095] Test indicators: D50=4.82μm, PDI=0.41, encapsulation rate 82.3%, thermal decomposition rate at 54℃ 4.85%, sodium salt needle-like crystals appear after 5 days of refrigeration at 0℃, and the energy consumption of a single batch of production is 40% higher than that of Example 1.
[0096] Comparative Example 2
[0097] Based on Example 1, the sodium dihydrogen phosphate buffer component was removed, and the salt-resistant compound emulsifier was replaced with a single alkylbenzene sulfonate sodium (3.7%), while the other conditions remained unchanged.
[0098] Test indicators: D50=3.45μm, PDI=0.31, encapsulation rate 87.5%, decomposition rate 4.92% after 14 days of heat storage at 54℃, and sodium salt precipitation at the bottom of the layered structure after 10 days of storage.
[0099] Comparative Example 3
[0100] The formulation is the same as in Example 1, except that the capsule wall is replaced with 6.3% isophorone diisocyanate and hexamethylene diisocyanate is not added. The rest of the process remains unchanged.
[0101] Test indicators: D50=3.65μm, PDI=0.28, encapsulation rate 89.6%; decomposition rate 4.36% after 14 days of heat storage at 54℃, slight crystallization after 7 days of low temperature, slow release rate too fast, and small-scale yellowing of leaf tips in northern japonica rice due to pesticide damage.
[0102] Comparative Example 4
[0103] The propylene carbonate in the formulation was replaced with an equal amount of dimethyl sulfoxide (DMSO), the amount of N-methylpyrrolidone remained unchanged, and the rest of the formulation composition and preparation process were the same as in Example 1.
[0104] Test indicators: D50=2.15μm, PDI=0.22, encapsulation rate 93.1%, sodium salt fine crystal precipitation after 10 days of cold storage at 0℃, excessive solubility of DMSO in water phase leading to decreased oil phase stability, decomposition rate of 2.85% after 14 days of hot storage at 54℃, and microcapsule wall strength lower than in Example 1.
[0105] Comparative Example 5
[0106] The sodium dihydrogen phosphate in the formula was replaced with an equal amount of sodium citrate, the amount of triethanolamine remained unchanged, and the rest of the formula composition and preparation process were the same as in Example 1.
[0107] Test indicators: D50=2.32μm, PDI=0.25, encapsulation efficiency 91.8%, narrow pH buffer range (7.5~8.2), weak resistance to acid and alkali fluctuations, pH drops to 6.8 after 15 days of storage, sodium salt hydrolysis is accelerated, decomposition rate is 3.92% after 14 days of heat storage at 54℃, and crystallization and stratification occur after 8 days of cold storage at 0℃.
[0108] Table 1. Comparison of physicochemical properties and stability of different formulations of bispyribac-sodium salt
[0109]
[0110] Test method:
[0111] pH adaptability test: Dilute with buffer water of pH 5.0, 6.0, 7.0, 8.0, and 9.0 according to the field recommendation multiples, let stand at 25℃ for 24 hours, observe the state of the diluted solution and detect changes in free active ingredients and particle size; Low temperature dilution stability: Dilute with standard hard water, let stand at 0±2℃ for 7 days, observe for crystallization, flocculation, and stratification, and detect residues on the sieve, free active ingredients, and particle size;
[0112] Low-temperature dilution stability test: Performed in accordance with GB / T19137-2003.
[0113] Table 2 Summary of the overall performance of different dosage forms
[0114]
[0115] Drug efficacy comparison experiment:
[0116] 1. Experimental crops and regions
[0117] Rice varieties tested: Early-maturing japonica rice from cold regions of northern China (mainly cultivated varieties such as Longjing series, Kongyu 131, and Suijing series);
[0118] Experimental locations: Cold-climate rice-growing areas in northern China, including Heilongjiang, Jilin, and Liaoning provinces;
[0119] Cultivation method: Rice transplanting field, seedling age 3-4 leaves, field water depth 3-5 cm.
[0120] 2. Test reagents and treatments
[0121] Example 1 of the present invention: 15% bispyribac-sodium salt microcapsule suspension
[0122] 15% Sodium Bismuth Substrate (SC)
[0123] Formula: 15.0% sodium bismuth subsalicylate, 3.0% polycarboxylate dispersant, 0.5% naphthalene sulfonate formaldehyde condensate, 1.5% sodium dodecyl sulfate wetting agent, 4.0% ethylene glycol antifreeze, 1.5% magnesium aluminum silicate, 0.3% xanthan gum, 0.3% organosilicon defoamer, 0.3% sodium benzoate preservative, and deionized water to 100%.
[0124] Preparation process: 1) Add deionized water to a stirred tank, add ethylene glycol, preservative, and defoamer, and stir at low speed for 3-5 minutes to dissolve evenly; 2) Add dispersant, wetting agent, and magnesium aluminum silicate, and stir at high speed (3000-4000 r / min) for 10 minutes; add bispyribac sodium technical grade, and continue high-shear dispersion for 15 minutes to obtain a coarse slurry; 3) Transfer the coarse slurry to a horizontal sand mill for wet sand milling, controlling the sand milling temperature ≤35℃, and sand mill to D50=5μm; 4) After sand milling, add pre-swollen xanthan gum solution while stirring, and stir at low speed for 20 minutes; 5) Filter impurities through a 75μm sieve, take samples to test the content, suspension rate, pH, and thermal storage stability, and obtain 15% bispyribac sodium suspension after passing the test.
[0125] 15% bispyribac-sodium wettable powder (WP)
[0126] Formula: 15.0% sodium bismuth subsalicylate, 3.0% sodium dodecyl sulfate wetting agent, 5.0% sodium lignosulfonate dispersant, 4.0% naphthalene sulfonate formaldehyde condensate, 3.0% silica, and light calcium carbonate to make up to 100%.
[0127] Preparation process: 1) Weigh all solid materials according to the formula and put them into a horizontal mixer for premixing for 25-30 minutes; 2) The mixture is fed into an air jet mill for ultrafine grinding, and the fineness of the powder is controlled to pass through a 45μm sieve by 98%; 3) The pulverized material is put back into the mixer for a second mixing for 20 minutes to ensure that the product is mixed evenly; 4) Sampling and testing of wetting time, suspension rate and pH; qualified measurement and packaging to obtain 15% bispyribac-sodium salt wettable powder.
[0128] 15% bispyribac-sodium salt dispersible granules (WG)
[0129] Formula: 15.0% sodium bismuth subsalicylate, 3.5% sodium dodecylbenzene sulfonate wetting agent, 6.0% polycarboxylate dispersant, 3.0% naphthalene sulfonate formaldehyde condensate, 6.0% ammonium sulfate disintegrant, 2.0% soluble starch, and kaolin filler to make up to 100%.
[0130] Preparation process: 1) Add sodium bispyribac-sodium salt, wetting agent, dispersant, disintegrant, and filler to a mixer and premix for 25 min; then perform air-jet ultrafine grinding, with 98% passing through a 45 μm sieve to obtain powder; 2) Feed the pulverized powder into a fluidized bed granulator; use deionized water as the binder spray liquid for bottom spray granulation in the fluidized bed; the inlet air temperature is 55-60℃, and the moisture content of the discharged particles is controlled to be ≤3%; 3) Select particles with a particle size of 0.2-0.8 mm by sieving; 4) Take samples to test the disintegration time, suspension rate, wettability, and thermal storage stability. After passing the tests, package the product to obtain 15% sodium bispyribac-sodium salt dispersible granules.
[0131] Water control (CK)
[0132] 3. Application design
[0133] Application time: 7-10 days after rice transplanting, when barnyard grass has 2-3 leaves;
[0134] Dosage: 28 mL / mu (uniform dosage of active ingredient);
[0135] Application method: Conventional spraying method, water usage 30 kg per mu, spray evenly;
[0136] Community design: Community area 15 m² 2 Each treatment was repeated 3 times, with randomized block arrangements.
[0137] 4. Safety Investigation Methods
[0138] Investigation period: 7 days and 14 days after medication;
[0139] Survey indicators: rice leaf color, stunted seedling condition, plant height, number of tillers, and pesticide damage level;
[0140] Standards for Grading Pesticide Damage:
[0141] Level 0 (No Phytotoxicity): Safe, with no symptoms of phytotoxicity.
[0142] Level 1 (Minor pesticide damage): Leaf tips turn slightly yellow.
[0143] Level 2 (Moderate pesticide damage): Leaves turn yellow, and growth is slightly inhibited.
[0144] Level 3 (Severe pesticide damage): Obvious yellowing, stunted growth, and seedling death.
[0145] Level 4 (Severe Herbicide Damage): Severe yellowing, inhibited tillering, seedling death.
[0146] 5. Methods for investigating drug efficacy
[0147] Investigation time: 15 days and 42 days after medication;
[0148] Survey method: Five points were sampled along the diagonal of each area, with each point measuring 0.25 m. 2 ;
[0149] Survey content: number of weeds, fresh weight, calculation of plant control efficacy and fresh weight control efficacy;
[0150] Calculation formula:
[0151] Control efficacy (%) = (Number of weeds in the control area - Number of weeds in the treatment area) / Number of weeds in the blank area ×100
[0152] Fresh weight control efficacy (%) = (fresh weight of weeds in the control area - fresh weight of weeds in the treatment area) / Fresh weight of weeds in blank areas ×100
[0153] Table 3. Comparison of safety and field efficacy of different formulations of bispyribac-sodium salt in cold-weather rice in northern China.
[0154]
[0155] Industrial-scale pilot production:
[0156] A pilot production line was built using the continuous flow process of this invention. The equipment has a processing capacity of 8~23 kg / h and runs continuously for 72 hours. 22 samples were taken and tested. The maximum particle size deviation was 1.72%, the encapsulation rate fluctuation was ≤1.15%, and there was no sodium salt crystallization or agglomeration. The production line operates in a closed and automated manner, reducing manual operation by about half. There is no organic solvent volatilization, and the discharge of high-salt wastewater is significantly reduced. It is suitable for the stable industrial production of sodium salts and meets the pesticide safety production and environmental emission standards.
[0157] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A highly stable sodium dihydrochloride microcapsule suspension with anti-crystallization properties, characterized in that, Made from the following raw materials by weight percentage: Bismuth subsalicylate sodium salt 5.0%~50.0%, capsule wall monomer 2.2%~8.5%, complex organic solvent 3.2%~14%, salt-resistant emulsifying dispersant 1.8%~5.2%, buffer salt stabilizer 0.25%~1.2%, thickener stabilizer 0.12%~0.55%, antifreeze 2.2%~5.5%, deionized water to 100%; The capsule wall monomer is selected from a mixture of isophorone diisocyanate and hexamethylene diisocyanate; The composite organic solvent is a mixture of N-methylpyrrolidone and propylene carbonate. The salt-resistant emulsifying dispersant is a compound system of anionic and nonionic surfactants.
2. The microcapsule suspension according to claim 1, characterized in that, The mass ratio of isophorone diisocyanate to hexamethylene diisocyanate is 2.2:1 to 4.2:
1.
3. The microcapsule suspension according to claim 1, characterized in that, The mass ratio of N-methylpyrrolidone to propylene carbonate is 1:4 to 4:
1.
4. The microcapsule suspension according to claim 1, characterized in that, The anionic surfactant is selected from sodium alkylnaphthalene sulfonate; The nonionic surfactant is selected from polyoxyethylene castor oil ether; The mass ratio of the anionic surfactant to the nonionic surfactant is 1:1.2 to 1:4.
2.
5. The microcapsule suspension according to claim 1, characterized in that, The buffer salt stabilizer is a mixture of triethanolamine and sodium dihydrogen phosphate, with a mass ratio of 1:1.8 to 1:2.
4.
6. The microcapsule suspension according to claim 1, characterized in that, The thickening stabilizer is xanthan gum; the antifreeze agent is ethylene glycol.
7. The microcapsule suspension according to claim 1, characterized in that, The microcapsule suspension has a median particle size D50 of 1.0~2.8 μm, a particle size distribution index (PDI) ≤0.17, a microcapsule encapsulation efficiency ≥95.2%, and a suspension efficiency ≥98.2%. The thermal storage stability conditions of the microcapsule suspension are: 54±2℃ sealed storage for 14 days, with a decomposition rate of ≤5%; the cold storage stability conditions are: 0±2℃ storage for 14 days, with no stratification, no precipitation, and no sodium salt crystallization.
8. A method for preparing a microcapsule suspension as described in any one of claims 1 to 7, characterized in that, Includes the following steps: A) Prepare oil-phase liquid and aqueous-phase liquid separately; The oil phase liquid comprises sodium bispyribac-sodium salt, capsule wall monomers, and a complex organic solvent; The aqueous phase liquid comprises a salt-resistant emulsifying dispersant, a buffer salt stabilizer, an antifreeze agent, and water; B) The oil phase liquid and the aqueous phase liquid are continuously emulsified through a microreactor to obtain an emulsion; C) The emulsion is polymerized and solidified to obtain polyurea-coated bis(propargyl) sodium salt microcapsules; D) The polyurea-coated sodium bispyribac-sodium salt microcapsules are post-processed and formulated to obtain the finished sodium bispyribac-sodium salt microcapsule suspension.
9. The preparation method according to claim 8, characterized in that, In step B), the microreactor is a cross-shaped microchannel reactor with an inner diameter of 550~950μm and an internal multi-layer shear diversion structure. The volume ratio of oil phase liquid to aqueous phase liquid feed is 1:1.5 to 1:4.5, and the feed accuracy of oil phase liquid and aqueous phase liquid is controlled at ±0.8%. The internal temperature of the microreactor is controlled at 43~63℃, the internal working pressure is 0.18~0.38MPa, the shear flow rate is 145~310mL / min, and the residence time is 18~48s.
10. The preparation method according to claim 8, characterized in that, In step C), the polymerization and curing are carried out under constant temperature conditions of 52~68℃ with continuous stirring for 2.2~4.2h; The polymerization and solidification are carried out in a tubular reactor, which is equipped with a jacketed constant temperature control system and a stirring speed of 85~145 r / min, and the reaction is carried out in a closed and continuous manner.
